Chemical Structure : Glofitamab
CAS No.: 2229047-91-8
货号: PC-Ab1034Not For Human Use, Lab Use Only.
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells a CD20/CD3 antibody (comprising two Fab regions for CD20 and one Fab region for CD3). Glofitamab redirects T cells to engage and eliminate malignant B cells..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells a CD20/CD3 antibody (comprising two Fab regions for CD20 and one Fab region for CD3). Glofitamab redirects T cells to engage and eliminate malignant B cells.
分子量 | ||
分子式 | Human IgG1-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Glofitamab; RO 7082859; RG-6026; RG6026; CD20/CD3 TCB 2; CD20/CD3 TCBs; Anti-CD20 CD3 TCB; Anti-CD20/CD3 bispecific monoclonal antibody; CD20-TCB; 2229047-91-8 |
1. 1, Hutchings M, et al. J Clin Oncol. 2021 Jun 20;39(18):1959-1970. 2, Surowka M, et al. MAbs. 2021 Jan-Dec;13(1):1967714. 3, Cremasco F, et al. PLoS One. 2021 Jan 6;16(1):e0241091. 4, Leuk Lymphoma. euk Lymphoma. 2021 Jul 15:1-11.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright